Christine Aylward is raising up to $100 million for a new fund called Magnetic Ventures, which will invest in early-stage medical technology companies. Magnetic Ventures. She was a Managing Director of Foresite Capital before
Christine has more than 20 years commercialization experience in healthcare and other industries as an executive and senior advisor. Her expertise includes marketing, business development, crisis communications, policy, public relations and financing strategies. Select past healthcare clients include Genomic Health (Nasdaq: GHI), Salix Pharmaceuticals (Nasdaq: SLXP), WebMD (Nasdaq: WBMD), and Celera. Previously Christine was Partner, Executive Vice President, and a member of the Executive Committee for Epoch Partners, a technology-focused investment bank acquired by Goldman Sachs. Prior to Epoch, Christine was the Senior Vice President of Ogilvy Worldwide, where she ran Ogilvy's San Francisco office.
At Hoffmann-La Roche, Christine was a key member of the global product launch team for polymerase chain reaction (PCR), a technology that has helped transform healthcare, and Roche Molecular Systems, spearheaded the first cross collaboration team between the pharmaceuticals and diagnostics divisions, was a member of the Rocephin product marketing team, and ultimately placed on an executive development program by the Executive Committee. At Rhone-Poulenc Rorer (now Sanofi) she worked in the Advanced Therapeutics and Oncology Division where she launched therapeutics including Taxotere, Gliadel, Rilutek, and Lovenox.
Most recently, Christine co-founded MakingOf, a digital media company in the entertainment sector.